PT Itama Ranoraya TbkISX:IRRA 81 Pretax Margin % is 5.69% as of Mar. 2026, which is 41% below its 10-year median of 9.64. GuruFocus rates ISX:IRRA with a GF Score™ of 81/100 and a GF Value™ of Rp535.69 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 117 Medical Distribution companies, PT Itama Ranoraya Tbk ranks better than 82.05% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
PT Itama Ranoraya Tbk Pretax Margin % Related Terms
PT Itama Ranoraya Tbk Pretax Margin % Historical Data
* Premium members only.
The historical data trend for PT Itama Ranoraya Tbk's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:IRRA vs MCK, CAH, COR: Pretax Margin % Comparison
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Itama Ranoraya Tbk (ISX:IRRA) has a Pretax Margin % of 5.69% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Itama Ranoraya Tbk and its competitors. This is 41% below median its historical median of 9.64. Over the past decade, PT Itama Ranoraya Tbk's Pretax Margin % has ranged from 1.13 to 16.25. According to the industry distribution chart, PT Itama Ranoraya Tbk ranks #21 out of 117 companies in the Medical Distribution industry, placing it in the top 17.9%.
Is PT Itama Ranoraya Tbk's Pretax Margin % too high?
PT Itama Ranoraya Tbk's current Pretax Margin % of 5.69% is 41% below median its 10-year median of 9.64. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 16.25. The Medical Distribution industry median Pretax Margin % is 2.37. PT Itama Ranoraya Tbk's value of 5.69% is 140.1% above this industry median. Based on the distribution chart, PT Itama Ranoraya Tbk ranks #21 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Pretax Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Itama Ranoraya Tbk ranks #21 out of 117 companies for Pretax Margin %. This places PT Itama Ranoraya Tbk in the top 18% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.37. PT Itama Ranoraya Tbk's value of 5.69% is 140.1% above this benchmark. Historically, PT Itama Ranoraya Tbk's own Pretax Margin % has ranged from 1.13 to 16.25 over the past decade. While the company's 10-year median is 9.64 vs. the industry median of 2.37, PT Itama Ranoraya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.37, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Itama Ranoraya Tbk's current Pretax Margin % of 5.69% is 140.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Itama Ranoraya Tbk and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Itama Ranoraya Tbk's current Pretax Margin % is 5.69%, which is 41% below median its own 10-year median of 9.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp535.69, compared to a current price of Rp374.00 — trading 30.2% below its estimated fair value. The current Pretax Margin % is 5.69%, which is 41% below median its 10-year median of 9.64 and 140.1% above the Medical Distribution industry median of 2.37. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Pretax Margin % is 5.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp374.00 is trading 30.2% below its estimated GF Value™ of Rp535.69.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Pretax Margin %: 5.69% (41% below median its 10-year median of 9.64)
GF Value™: Rp535.69 vs. price of Rp374.00 (30.2% below fair value)
Industry Position: 140.1% above the Medical Distribution median (#21 of 117)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
